Please login to the form below
4
Revenue 2017Sanofi
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sanofi's 2013 sales performance.
Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the European Commission as the first and only targeted medicine for eosinophilic oesophagitis (EoE), the companies announced. ... Naimish Patel, head of global development, immunology and
Sanofi/Regeneron’s Dupixent recommended by CHMP for atopic dermatitis in children
Sanofi and Regeneron’s Dupixent (dupilumab) has been recommended for use in the EU to treat severe atopic dermatitis in children aged six months to five years who are candidates for
Moderna reports positive phase 3 data for its RSV vaccine for older adults
AstraZeneca and Sanofi’s antibody treatment Beyfortus (nirsevimab) received European Commission approval in November 2022 to prevent RSV in newborns and infants and is currently under review by the FDA.
California sues largest US insulin manufacturers and PBMs for overpricing
Eli Lilly, Novo Nordisk and Sanofi produce over 90% of the global insulin supply. ... Eli Lilly, Novo Nordisk and Sanofi produce over 90% of the global insulin supply and the PBMs CVS Caremark, Express Scripts and OptumRx administer pharmacy benefits for
Sanofi and Innate Pharma expand cancer therapeutics collaboration
Under the expanded collaboration, Sanofi will have the option to add up to two additional ANKET targets. ... highly synergistic with Sanofi’s allogeneic NK cell platform, engineered lymphokines that stimulate NK cells and growing Immuno-oncology
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- GSK to submit drug application for new antibiotic to US FDA
- EU outlines measures to mitigate antibiotic shortage across Europe
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
PMHub
SEVEN STONES COLLECTIVE
Hello. We are the Total Health creative agency. It’s our collective mix of talent that gets us to truly different...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
